256 related articles for article (PubMed ID: 11375359)
1. Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up.
Trento M; Passera P; Tomalino M; Bajardi M; Pomero F; Allione A; Vaccari P; Molinatti GM; Porta M
Diabetes Care; 2001 Jun; 24(6):995-1000. PubMed ID: 11375359
[TBL] [Abstract][Full Text] [Related]
2. A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care.
Trento M; Passera P; Borgo E; Tomalino M; Bajardi M; Cavallo F; Porta M
Diabetes Care; 2004 Mar; 27(3):670-5. PubMed ID: 14988283
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
Aiello LP; Ayala AR; Antoszyk AN; Arnold-Bush B; Baker C; Bressler NM; Elman MJ; Glassman AR; Jampol LM; Melia M; Nielsen J; Wolpert HA;
JAMA Ophthalmol; 2015 Aug; 133(8):888-96. PubMed ID: 25996273
[TBL] [Abstract][Full Text] [Related]
4. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
Davis TM; Cull CA; Holman RR;
Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Self-Management Education and Medical Nutrition Therapy: A Multisite Study Documenting the Efficacy of Registered Dietitian Nutritionist Interventions in the Management of Glycemic Control and Diabetic Dyslipidemia through Retrospective Chart Review.
Marincic PZ; Salazar MV; Hardin A; Scott S; Fan SX; Gaillard PR; Wyatt C; Watson L; Green P; Glover P; Hand M
J Acad Nutr Diet; 2019 Mar; 119(3):449-463. PubMed ID: 30219311
[TBL] [Abstract][Full Text] [Related]
6. The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trial.
Weinger K; Beverly EA; Lee Y; Sitnokov L; Ganda OP; Caballero AE
Arch Intern Med; 2011 Dec; 171(22):1990-9. PubMed ID: 21986346
[TBL] [Abstract][Full Text] [Related]
7. A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA).
Gagliardino JJ; Etchegoyen G;
Diabetes Care; 2001 Jun; 24(6):1001-7. PubMed ID: 11375360
[TBL] [Abstract][Full Text] [Related]
8. ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial.
Franciosi M; Lucisano G; Pellegrini F; Cantarello A; Consoli A; Cucco L; Ghidelli R; Sartore G; Sciangula L; Nicolucci A;
Diabet Med; 2011 Jul; 28(7):789-96. PubMed ID: 21342243
[TBL] [Abstract][Full Text] [Related]
9. Changes in depressive symptoms and glycemic control in diabetes mellitus.
Georgiades A; Zucker N; Friedman KE; Mosunic CJ; Applegate K; Lane JD; Feinglos MN; Surwit RS
Psychosom Med; 2007 Apr; 69(3):235-41. PubMed ID: 17420441
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
[TBL] [Abstract][Full Text] [Related]
11. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
Harris MI;
Diabetes Care; 2001 Jun; 24(6):979-82. PubMed ID: 11375356
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
13. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
14. Glycaemic control in type 2 diabetes: the impact of body weight, beta-cell function and patient education.
Chan WB; Chan JC; Chow CC; Yeung VT; So WY; Li JK; Ko GT; Ma RC; Cockram CS
QJM; 2000 Mar; 93(3):183-90. PubMed ID: 10751238
[TBL] [Abstract][Full Text] [Related]
15. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.
Guerci B; Drouin P; Grangé V; Bougnères P; Fontaine P; Kerlan V; Passa P; Thivolet Ch; Vialettes B; Charbonnel B;
Diabetes Metab; 2003 Dec; 29(6):587-94. PubMed ID: 14707887
[TBL] [Abstract][Full Text] [Related]
16. Effects of self-management training in Type 2 diabetes: a randomized, prospective trial.
Kulzer B; Hermanns N; Reinecker H; Haak T
Diabet Med; 2007 Apr; 24(4):415-23. PubMed ID: 17298590
[TBL] [Abstract][Full Text] [Related]
17. Long-term effectiveness of a quality improvement program for patients with type 2 diabetes in general practice.
Renders CM; Valk GD; Franse LV; Schellevis FG; van Eijk JT; van der Wal G
Diabetes Care; 2001 Aug; 24(8):1365-70. PubMed ID: 11473071
[TBL] [Abstract][Full Text] [Related]
18. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
19. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
[TBL] [Abstract][Full Text] [Related]
20. Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.
Becker A; van der Does FE; van Hinsbergh VW; Heine RJ; Bouter LM; Stehouwer CD
Neth J Med; 2003 Apr; 61(4):129-36. PubMed ID: 12852722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
